Thus, following SCLC transformation, cancer cells became insensitive to EGFR-TKIs partly by downregulating the expression of EGFR protein and not by acquiring a secondary EGFR-mutation such as T790M[9,19,38]. The gene discussed is EGFR; the disease is small cell lung carcinoma.